Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

OptiMedica (Sunnyvale, CA), a commercial-stage medical device company focused on laser technology for cataract surgery, closed a $35M Series E financing. Participants include Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital.

Sensimed (Switzerland), a commercial-stage medical device company focused on glaucoma-monitoring, closed a $22M Series C financing. Participants include Wellington Partners, Agate Medical Investments, Vinci Capital/Renaissance PME, Sandoz Family Foundation and ELM Development. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive […]

PowerVision (Belmont, CA) a development-stage medical device company focusing on an accommodating intraocular lens to allow for dynamic near and far focus adjustments, closed a $13.2M Series C financing, bringing the total round to $37.2M. Participants include Johnson & Johnson Development Corp., Venrock, Advanced Technology Ventures and Frazier Healthcare Ventures.

AcuFocus (Irvine, CA) a commercial-stage medical device company focused on corneal inlays for near-vision loss, closed a $40M Series F financing. Participants include Medtronic, SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Bausch & Lomb.

MedLumics (Spain) a development-stage diagnostic device company focused on optical coherence tomography imaging for ophthalmology and intravascular imaging in cardiology, dermatology and dentistry, closed a $3.25M Series A financing. Participants include Ysios Capital Partners and Caixa Capital.

Transcend Medical (Menlo Park, CA) a clinical-stage medical device company focused on the treatment of glaucoma, closed a $16 Series B, bringing the total round to $51M. Participants include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners. Thanx for […]

Averdo (Waltham, MA) a commercial-stage ophthalmology medical device company focused on procedures for biomechanically strengthening and modifying the cornea, closed on $25M Series C financing. Participants include SCP Vitalife, Aperture Venture Partners, Prism VentureWorks, De Novo Ventures, Flagship Ventures, Borealis Ventures and Echelon Ventures. Thanx for your patience as we catch-up.

PixelOptics (Roanoke, VA) a commercial-stage developer of dynamic electronic focusing eyeglasses, closed a $35M Series D financing. Participants include Safeguard Scientifics, Delphi Ventures, Carlyle Group, Longitude Capital and Stark Investments.

Glaukos (Laguna Hills, CA) a clinical-stage ophthalmology medical device company focused on the management of open-angle glaucoma, closed a $29.5M Series E. Participants include OrbiMed, Frazier Healthcare Ventures, InterWest Partners, Domain Associates and Versant Ventures.

Retina Implant (Germany) clinical-stage medical device developer of sub-retinal implants for the treatment of retinitis pigmentosa, closed a $18M Series C financing. Participants include the Drosten Group.

VisionCare Ophthalmic Technologies (Saratoga, CA) a commercial-stage medical device company focused on advanced age-related macular degeneration, closed a $31M Series E financing. Participants include Saints Venture Capital, Giza Ventures, Generali Financial Holdings, BSI, Pitango Venture Capital, Three Arch Partners, Onset Ventures and Infinity CSVC Management.

ReVision Optics (Lake Forest, CA) a clinical-stage medical device company focused on a corneal inlay for presbyopia, closed a $35M Series D financing. Participants include ProQuest Investments, Domain Associates, Canaan Partners and InterWest Partners.

AqueSys (Irvine, CA) a clinical-stage medical device company focused on implants for the treatment of glaucoma, closed a $25M Series C financing. Participants include Longitude Capital, Rho Ventures, Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.

« Previous Entries  Next Page »

to top of page...